Analgesics Market Set for Explosive Growth, Projected to Reach USD 50.7 billion by 2030 at a CAGR of 6.6%

According to the report, the global analgesics industry was estimated at $26.7 billion in 2020, and is anticipated to hit $50.7 billion by 2030, registering a CAGR of 6.6% from 2021 to 2030. 

Key Takeaways:

  • Growing Demand: The analgesics market has been experiencing a steady increase in demand globally. This is primarily driven by factors such as a rise in chronic diseases, an aging population, and an increase in surgical procedures.
  • Over-the-Counter Dominance: Over-the-counter (OTC) analgesics, including nonsteroidal anti-inflammatory drugs (NSAIDs) and acetaminophen, account for a significant portion of the analgesics market. These medications are easily accessible and provide relief for mild to moderate pain without the need for a prescription.
  • Prescription Analgesics: Stronger analgesics, such as opioids, are available by prescription and are typically used for severe pain management. However, due to concerns about addiction and misuse, there has been increased scrutiny and regulation around the prescription and use of opioids.
  • Regional Variations: The analgesics market exhibits regional variations in terms of product preferences, availability, and regulations. Factors such as cultural practices, healthcare infrastructure, and regulatory frameworks influence the market dynamics in different regions.

Request Sample Copy of Report:

https://www.alliedmarketresearch.com/request-sample/1254

Market Drivers:

  • Increasing Prevalence of Chronic Pain: Chronic pain conditions, such as arthritis, back pain, and neuropathic pain, are on the rise globally. The aging population, sedentary lifestyles, and the prevalence of chronic diseases contribute to the increased incidence of chronic pain. As a result, there is a higher demand for analgesics to manage these conditions.
  • Growing Surgical Procedures: The number of surgical procedures performed worldwide continues to increase. Surgeries often entail post-operative pain, requiring effective analgesics for pain management during the recovery period. The rising number of surgical interventions, including orthopedic, dental, and cosmetic surgeries, drives the demand for analgesics.

Market Segmentation:

Product Type:

a. Nonsteroidal Anti-inflammatory Drugs (NSAIDs): This category includes medications like ibuprofen, naproxen, and aspirin, which provide pain relief and reduce inflammation.

b. Acetaminophen: Also known as paracetamol, acetaminophen is commonly used for mild to moderate pain and fever reduction.

c. Opioids: Strong analgesics, such as morphine, oxycodone, and hydrocodone, are available by prescription for severe pain management.

d. Others: This category includes topical analgesics, combination products, and emerging analgesic therapies.

End User:

a. Hospitals and Clinics: Analgesics used in hospitals, surgical centers, and outpatient clinics.

b. Homecare: Analgesics used by patients at home for self-medication and pain management.

c. Ambulatory Surgical Centers: Analgesics used in same-day surgical centers.

Geography:

a. North America: Includes the United States, Canada, and other countries in the region.

b. Europe: Includes countries in Western and Eastern Europe.

c. Asia-Pacific: Includes countries such as China, India, Japan, and others in the region.

d. Latin America: Includes countries in Central and South America.

e. Middle East and Africa: Includes countries in the Middle East and African continent.

Procure Complete Report at 15% Discount (258 Pages) 

https://www.alliedmarketresearch.com/purchase-enquiry/1254

Competitive Landscape:

  • Novartis AG
  • Eli Lily and Company
  • Glaxosmithkline PLC
  • Pfizer Inc.
  • Sanofi
  • Bayer AG
  • Johnson & Johnson
  • Bristol Myer’s Squibb
  • Reckitt Benckiser
  • Endo Pharmaceuticals

Request for Customization – https://www.alliedmarketresearch.com/request-for-customization/1254

VALUE PROPOSITIONS RELATED TO THE REPORT:

  • Powered with Complimentary Analyst Hours and Expert Interviews with Each Report
  • Comprehensive quantitative and qualitative insights at segment and sub-segment level
  • Covid 19 impact trends and perspective
  • Granular insights at global/regional/country level
  • Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment
  • Blanket coverage on competitive landscape

Get an access to the library of reports at any time from any device and anywhere. For more details, follow the link: https://www.alliedmarketresearch.com/library-access

About Allied Market Research:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.

Contact:

David Correa  
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: 1-800-792-5285
UK: +44-845-528-1300 
Hong Kong: +852-301-84916  
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
help@alliedmarketresearch.com   
Web: https://www.alliedmarketresearch.com

Leave a comment

Your email address will not be published. Required fields are marked *